Medarex in two deals

Eos (South San Francisco, Calif.) will identify targets for cancer and other diseases, and will use MEDX's HuMAb-Mouse technology to develop human antibodies

Read the full 236 word article

How to gain access

Continue reading with a
two-week free trial.